WebbDr. Sharon Benzeno is the Chief Commercial Officer, Immune Medicine and leads the Drug Discovery group of Adaptive Biotechnologies, a commercial-stage biotech company that … WebbDr. Sharon Benzeno is the Chief Business Development Officer and leads the Drug Discovery group at Adaptive. Sharon oversees the use of the company’s immune …
Sharon - Benzeno - PMWC Precision Medicine World Conference
WebbUniquely equipped to achieve our bold vision, Adaptive Leadership brings expertise and experience that support our mission. Skip to content Hope restored: The critical role that … Webb12 jan. 2024 · Adaptive Biotechnologies ... Heather M. Callaway, 1 Kathryn M. Hastie, 1 Sharon L. Schendel, 1 Haoyang Li, 1 Xiaoying Yu, 1 Jeremy Shek, 1 Tierra Buck, 1 Sean Hui, 1 Dan Bedinger, 2 Camille Troup, 2 S. Moses Dennison, 3 Kan Li, 3 Michael Alpert, 4 Charles C. Bailey, 4 Sharon Benzeno, 5 Jody L. Bonnevier, 6 Jin-Qiu Chen, 7 Charm Chen ... simplicity\u0027s e6
Sharon Benzeno - Chief Commercial …
Webb26 okt. 2024 · Chair: Sharon Benzeno, Adaptive Biotechnologies Biomarkers to Guide Immunotherapy Chair: TBD Additional Emerging Therapeutics track themes focus on COVID Therapeutics on Day 1 The COVID Therapeutics Track (Day 1) SARS-CoV-2 vaccines: different vaccine strategies and robustness to viral evolution WebbTrack 1 - January 26 9.00 A.M.-4.30 P.M. Track Chair: Sharon Benzeno, Adaptive Biotechnologies. PMWC 2024 Luminary Award Ceremony. Honoree: Bruce Levine, University of Pennsylvania. Advance and Optimize Cell Therapies in Oncology (PANEL) Chair: Sharon Benzeno, Adaptive Biotechnologies. - Ira Mellman, Genenetch. WebbSharon Benzeno, PhD, MBA is the Chief Commercial Officer, Immune Medicine and leads the Drug Discovery group of Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Before joining Adaptive in 2014, Dr Benzeno … simplicity\\u0027s e7